Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review

Li, Rui, Zhang, Ping, Barker, Lawrence E., Chowdhury, Farah M., Zhang, Xuanping·2010·Diabetes Care

Cited by (487)

Items 301–400 of 487

  1. Diabetes mellitus monitoring and control among adults in Australian general practice: a national retrospective cohort study
    Mingyue Zheng, Carla Bernardo, Nigel Stocks, Peng Hu, David Alejandro González‐Chica · 2023 · BMJ Open
  2. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening
    Weichen Yuan, Wei Xu, Xin Xu, Bo Qu, Fangkun Zhao · 2024 · Scientific Reports
  3. Does diabetes prevention pay for itself? Evaluation of the M.O.B.I.L.I.S. program for obese persons
    Jan Häußler, Friedrich Breyer · 2015 · The European Journal of Health Economics
  4. Practical Implementation of Diabetes Technology: Real‐World Use
    Laurel H. Messer, STUART ALAN WEINZIMER · 2020 · Diabetes Technology & Therapeutics
  5. Epidemiology and Health Care Cost of Diabetic Foot Problems
    Robert G. Frykberg, Jeremy J. Cook, Donald C. Simonson · 2018 · Contemporary diabetes
  6. The Economic Costs of Diabetes
    Joel Rodríguez‐Saldaña · 2023 · Springer eBooks
  7. Cardiovascular disease (CVD)
    Elvira DAndrea, I. Nagyova, P. Villari · 2015 · Springer eBooks
  8. When is an ounce of prevention worth a pound of cure? Identifying high-risk candidates for case management
    David R. Anderson, Margrét V. Bjarnadóttir · 2016 · IIE Transactions on Healthcare Systems Engineering
  9. Costs of people with diabetes in relation to average glucose control: an empirical approach controlling for year of onset cohorts
    Beatriz Rodríguez-Sánchez, Talitha Feenstra, Henk J. G. Bilo, Rob J.M. Alessie · 2019 · The European Journal of Health Economics
  10. Prevención primaria de diabetes tipo 2 en Argentina: estudio piloto en la provincia de Buenos Aires
    Juan José Gagliardino, Graciela S Etchegoyen, Marcelo Javier Bourgeois, Gabriel Fantuzzi, Silvia García, Lorena González, Jorge Federico Elgart, Matías Ré, Alberto Omar Ricart, Juan Pablo Antonio Ricart et al. · 2016 · Revista Argentina de Endocrinología y Metabolismo
  11. Differences in Continuous Glucose Monitoring Metrics Between Prediabetes and Normoglycemia: A Systematic Review and Meta-Analysis
    Gabriella Rákóczi, Judit Nagy, Shaghayegh Jozaee, Shirin Jozaee, Boglárka Lilla Szentes, Jimin Lee, Anett Rancz, Péter Jenő Hegyi, Gergely Agócs, Emese Sipter · 2026 · Journal of Diabetes Science and Technology
  12. Precise glucose measurement in sodium fluoride-citrate plasma affects estimates of prevalence in diabetes and prediabetes
    Geronimo Heilmann, Sandra Trenkamp, Clara Möser, Maria Bombrich, Martin Schön, Iryna Yurchenko, Klaus Straßburger, Marcos Matabuena Rodríguez, Oana‐Patricia Zaharia, Volker Burkart et al. · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)
  13. Assessment of sex disparities in prevalence of diagnosed and undiagnosed diabetes mellitus: results from the Bangladesh demographic and health survey data
    Shakib Ahmed Suhel, Nayma Akther, Shofiqul Islam, Nipa Rani Dhor, Masud Ahmed, Ahmed Hossain · 2024 · BMC Endocrine Disorders
  14. Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations
    Zixuan Jin, Joshua Rothwell, Ka Keat Lim · 2025 · Value in Health
  15. Charting the landscape of marketing communication in higher education: A comprehensive thematic review and future research directions
    Sana Khanam, Rakesh Mohan Joshi · 2025 · Journal of Marketing Communications
  16. Long-term cost-effectiveness of health behaviour intervention to manage type 2 diabetes in Nepal
    Padam Kanta Dahal, Corneel Vandelanotte, Lal Bahadur Rawal, Rashidul Alam Mahumud, Grish Paudel, Melanie Lloyd, Yeji Baek, Biraj Man Karmacharya, Tomohiko Sugishita, Zanfina Ademi · 2025 · BMC Medicine
  17. Policy Framework for Covering Preventive Services Without Cost Sharing
    Stephanie C. Chen, Steven D. Pearson · 2016 · JAMA Internal Medicine
  18. Improving Diabetic Retinopathy Screening Among Patients With Diabetes Mellitus Using the Define, Measure, Analyze, Improve, and Control Process Improvement Methodology
    Usha Kollipara, Shilu Varghese, Jackie Mutz, Joseph Putra, Puneet Bajaj, Sasan Mirfakhraee, Alex H. Tessnow, Jason Fish, Sadia Ali · 2021 · Journal for Healthcare Quality
  19. Clinical preventive services to reduce pandemic deaths
    Siddarth Agrawal, Justyna Gołębiowska, Bartłomiej Bartoszewicz, Sebastian Makuch, Grzegorz J. Mazur · 2020 · Preventive Medicine Reports
  20. Determination of Time in Range Associated With HbA1c ≤7% in a Prospective Cohort of Patients With Type 1 Diabetes Using Continuous Glucose Monitoring for Three Months
    Ana María Gómez, Diana Cristina Henao C, Martín Rebolledo, Pablo Jaramillo, Óscar Múñoz, Laura María Niño G, Carlos Augusto Yepes · 2022 · Journal of Diabetes Science and Technology
  21. Empowering Diabetes Patient with Mobile Health Technologies
    M. Krošel, Lana Švegl, Luka Vidmar, D. Dinevski · 2016 · InTech eBooks
  22. Differences in Health Services Utilization and Costs between Antihypertensive Medication Users Versus Nonusers in Adults with Diabetes and Concomitant Hypertension from Medical Expenditure Panel Survey Pooled Years 2006 to 2009
    Mary Lynn Davis–Ajami, Jun Wu, Jeffrey Craig Fink · 2014 · Value in Health
  23. The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases
    Penny M. Kris‐Etherton, Kristina H. Petersen, Benoı̂t Lamarche, Wahida Karmally, John R. Guyton, Catherine M. Champagne, Alice Hinda Lichtenstein, George A. Bray, Frank M. Sacks, Kevin Carl Maki · 2024 · Journal of clinical lipidology
  24. System Accuracy Evaluation of the GlucoRx Nexus Voice TD-4280 Blood Glucose Monitoring System
    Muhammad Arif Khan, Keith Broadbent, M. Morris, David L. Ewins, Franklin Joseph · 2014 · Disease Markers · Retracted
  25. The prevalence of diabetic retinopathy and its effect on social well-being and health related quality of life in children and young adults with type 1 diabetes
    Virva Hannula · 2015
  26. Cost-effectiveness analysis of COVID-19 vaccination: A review of some vaccination models
    Rehana Naz, Andrew Omame, Mariano Torrisi · 2024 · Partial Differential Equations in Applied Mathematics
  27. Exploring the association between type 2 diabetes and fecal incontinence in american adults: insights from a large cross-sectional study
    L. Li, Li-Ming Liang, Hong-ye Ji, Can Zhang, Man Wang, Hongsheng Liu · 2024 · International Journal of Colorectal Disease
  28. Diabetes in the Shadow of Conflict: Understanding and Addressing the Crisis in Gaza
    Abdel Rahman Feras AlSamhori, Jehad Feras AlSamhori, Abdullah Firas Al-Deffaie, Leen Anwer Saleh Alhadidi, Michael Khoury, Noor S. Bader, Feras AlSamhori, Mohammad Al-Jafari · 2025 · JAP Academy Journal
  29. Population Health as a Means for Health Care Organizations to Deliver Value
    Robert M. Jacobson, George J Isham, Lila J. Finney Rutten · 2015 · Mayo Clinic Proceedings
  30. Computer simulation models of pre-diabetes populations: a systematic review protocol
    José Leal, Waqar Khurshid, Eva Pagano, Talitha Feenstra · 2017 · BMJ Open
  31. Cost-effectiveness of financial incentives to improve glycemic control in adults with diabetes: A pilot randomized controlled trial
    Leonard E. Egede, Rebekah J. Walker, Clara E. Dismuke‐Greer, Sarah Pyzyk, Aprill Z. Dawson, Joni Strom Williams, Jennifer Annette Campbell · 2021 · PLoS ONE
  32. Simulating lifestyle and medical interventions to prevent type-2 diabetes: an economic evaluation for Belgium
    Désirée Vandenberghe · 2021 · The European Journal of Health Economics
  33. National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001–2018
    Shihchen Kuo, Chun-Ting Yang, William H. Herman, Lynda D. Lisabeth, Wen Ye · 2022 · Diabetes Care
  34. LifeSteps: An Evidence-based Health Promotion Program for Underserved Populations – A Community Service Learning Approach
    Melanie Austin-McCain · 2015 · The Open Journal of Occupational Therapy
  35. Is screening for microalbuminuria in patients with type 2 diabetes feasible in the Cape Town public sector primary care context? A cost and consequence study
    HO Ibrahim, Dusica Stapar, Robert James Mash · 2013 · South African Family Practice
  36. Identifying a Potential Screening Tool for Prediabetes: The Association of Hemoglobin A1c and a Test of Physical Fitness
    Andrew M Timboe, Robert M. Lystrup, Christy J. W. Ledford, Paul F. Crawford · 2018 · Military Medicine
  37. Integrative transcriptomic analysis of pancreatic islets from patients with prediabetes/type 2 diabetes
    María Victoria Mencucci, Luis Emilio Flores, Juan José Gagliardino, Martı́n C. Abba, Bárbara Maiztegui · 2020 · Diabetes/Metabolism Research and Reviews
  38. Cost-effectiveness of Telephone-Delivered Education and Behavioral Skills Intervention for African American Adults with Diabetes
    Leonard E. Egede, Clara Elizabeth Dismuke, Christian Eiler, Joni Strom Williams, Rebekah J. Walker · 2021 · Ethnicity & Disease
  39. Quality indicators for diabetes prevention programs in health care targeted at people at high risk.
    Jaana Lindström, Katja Wikström, Marina Maggini, Andrea Icks, Silke Kuske, Ulrike Rothe, Monica Sørensen, Jelka Zaletel · 2015 · PubMed
  40. Use of DNA sequencing for noncommunicable diseases in low‐income and middle‐income countries' primary care settings: A narrative synthesis
    Luz María González-Robledo, Edson E Servan-Mori, Anaid Casas‐López, Sergio Flores‐Hernández, María Lilia Bravo, Gilberto Sánchez‐González, Gustavo Nígenda · 2018 · The International Journal of Health Planning and Management
  41. Healthcare Resource Utilization and Costs in an At-Risk Population With Diabetic Retinopathy
    Vivian Rajeswaren, Vivian Lu, Hongan Chen, Jennifer L. Patnaik, Niranjan Manoharan · 2024 · Translational Vision Science & Technology
  42. Increased prevalence of diabetes mellitus and its metabolic risk factors from 2002 to 2017 in Shanghai, China
    Qinping Yang, Jingyan Tian, Yanyun Li, Qinghua Yan, Wenli Xu, Chaowei Fu, Minna Cheng, Yan Shi · 2024 · Journal of Diabetes
  43. Exploring prediabetes remission in public primary care in Mexico: A cascade analysis
    Rubén Silva-Tinoco, Lilia Castillo‐Martínez, Alejandra Pérez-Galván, Viridiana de la Torre-Saldaña, EILEEN B. GUZMAN-OLVERA, Christian Hinojosa-Segura, Alejandro Ávalos-Bracho · 2025 · Clinical Medicine
  44. A Multicenter Pilot Randomized Trial of a Lifestyle Intervention to Prevent Type 2 Diabetes in High-Risk Individuals
    Raira Pagano, Thatiane Lopes Valentim Di Paschoale Ostolin, Danielle Cristina Fonseca, Aline Marcadenti, Ana Paula Perillo Ferreira Carvalho, Bernardete Weber, Carla Daltro, Enilda Maria de Sousa Lara, F.C.M. Nolêto, Josefina Bressan et al. · 2025 · Nutrients
  45. Cost-effectiveness of community diabetes screening: Application of Akaike information criterion in rural communities of Nigeria
    Anayochukwu Edward Anyasodor, Ezekiel Uba Nwose, Phillip Bwititi, Ross Stuart Richards · 2022 · Frontiers in Public Health
  46. Should physicians team up to treat chronic diseases?
    Malte Griebenow · 2023 · Journal of Health Economics
  47. Development and validation of interprofessional health education module for the management of gestational diabetes mellitus
    Ashwini K Shetty, Madhavi Reddy, Nitin J. Patil, Senthil E Kumaran, Pradeep Tarikere Satyanarayana, SR Sheela, A Raveesha, Sudha Reddy V. R., Gagan Bajaj · 2024 · Journal of Education and Health Promotion
  48. Long-term evacuation and obesity: a 12-year follow-up comparative study of residents inside and outside Katsurao Village after the Fukushima nuclear disaster
    Naomi Ito, Morihito Takita, Nobuaki Moriyama, Isamu Amir, Ayako Furuyama, Hiroaki Saito, Toshiki Abe, Chika Yamamoto, Mika Sato, Tianchen Zhao et al. · 2024 · Frontiers in Public Health
  49. IMAGE guidelines: potential impact for diabetes primary preventive care in the EU
    Peter E. H. Schwarz · 2011 · Diabetes Management
  50. Diabetes: A Primary Health Care Approach
    Meltem Zeytinoglu, Elbert S. Huang · 2015 · Springer eBooks
  51. Type 2 diabetes mellitus, physical activity, yoga and telomere length: A literature review
    Reepa Avichal Ughreja, Reena Ughreja · 2019 · Journal of Metabolic Health
  52. Estimated number of eligible Part B beneficiaries for the medicare diabetes prevention program at the county level and by urban–rural classification
    Boon Peng Ng, Yiling J. Cheng, Stephanie Rutledge, Michael J. Cannon, Ping Zhang, Bryce D. Smith · 2020 · PLoS ONE
  53. Cost effectiveness of nonpharmacological prevention programs for diabetes: A systematic review of trial‐based studies
    Yongyi Xiong, Zhaohua Huo, Samuel Yeung Shan Wong, Benjamin Hon Kei Yip · 2023 · Chronic Diseases and Translational Medicine
  54. Is Prediabetes Overdiagnosed? Yes: A Patient-Epidemiologist’s Experience
    Rani Marx · 2024 · The Annals of Family Medicine
  55. How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial
    Michael Laxy, Ed Wilson, Clare E. Boothby, Simon J. Griffin · 2018 · BMJ Open
  56. Cycle of Care for people with diabetes: an equitable initiative?
    Kate O’Neill, Sheena McHugh, Patricia M. Kearney · 2019 · HRB Open Research
  57. Cut-off values for step count and TV viewing time as discriminators of hyperglycaemia in Brazilian children and adolescents
    Alex Pinheiro Gordia, Teresa Maria Bianchini de Quadros, Luciana Rodrígues Silva, Jorge Augusto Pinto Silva Mota · 2015 · Annals of Human Biology
  58. Nearly Invisible: The Psychosocial and Health Needs of Women with Male Partners in Prison
    Cheryl L. Cooke · 2014 · Issues in Mental Health Nursing
  59. Longitudinal trends in use and costs of prescription medication in patients with type 1 diabetes: The impact of renal disease
    Raija Lithovius, Valma Harjutsalo, Markku Saraheimo, Carol M. Forsblom, Per‐Henrik Groop, on behalf of the FinnDiane Study Group · 2012 · Annals of Medicine
  60. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study
    Balkau, Beverley, Halimi, Serge, Blickle, Jean-Frédéric, Vergès, Bruno, Avignon, Antoine, Attali, Claude, Chartier, Isabelle, Amelineau, Elisabeth · 2016 · Annales d'Endocrinologie
  61. Costs and Cost-Effectiveness of Interventions and Policies to Prevent and Treat Cardiovascular and Respiratory Diseases
    Thomas Andrew Gaziano, Marc Suhrcke, Elizabeth Brouwer, Carol Levin, Irina A. Nikolic, Rachel A. Nugent · 2017 · Europe PMC (PubMed Central)
  62. Long Noncoding Rnas As Novel Biomarkers for Type 2 Diabetes
    Han Zhu, Xiaolan Bian, Jingru Gong, Ping Yu, Huiping Lu · 2020 · Biomarkers in Medicine
  63. Economic Evaluation of the GOAL Lifestyle Intervention to Prevent Type-2 Diabetes
    Jan Häußler, Nelli E. Hankonen, Pilvikki Absetz · 2015 · RePEc: Research Papers in Economics
  64. Diabetes diagnosis based on glucose control levels and time until diagnosis: a regression discontinuity approach to assess the effect on direct healthcare costs
    Toni Mora, Beatriz Rodríguez-Sánchez · 2025 · Health Economics Review
  65. Cost-Effectiveness of Primary Prevention of Stroke in Type 2 Diabetes in the United States: A Microsimulation Analysis
    Wen Ye, Xiaqing Jiang, Jing Li, Shihchen Kuo, Christopher J. Becker, William H. Herman, Weizhou Zhang, Lewis B. Morgenstern, Lynda D. Lisabeth · 2025 · Journal of General Internal Medicine
  66. High-Risk Versus Population Prevention Strategies for NCDs: Geoffrey Rose Revisited in the Twenty-First Century
    John William Frank, Ruth Gillian Jepson · 2013 · Springer eBooks
  67. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
    Peter E. H. Schwarz, Patrick Timpel · 2016 · Bulletin of the Karaganda University “Biology medicine geography Series”
  68. Impact of Diabetes Complications
    Ivica Smokovski · 2020 · Managing Diabetes in Low Income Countries
  69. A methodological quality review of citations of randomized controlled trials of diabetes type2 in leading clinical practice guidelines and systematic reviews
    Azadeh Aletaha, Mohammad‐Reza Malekpour, Abbasali Keshtkar, Hamid Reza Baradaran, Shahram Sedghi, Yasaman Mansoori, Mehdi Hajiani, Somayeh Delavari, Farzaneh Habibi, Maryam Razmgir et al. · 2023 · Journal of Diabetes & Metabolic Disorders
  70. Prevention of diabetes in Mexico: pragmatic solutions for a complex problem
    Carlos Alberto Aguilar-Salinas, Héctor Bourges Rodríguez, Ernestina Polo‐Oteyza · 2017 · Nutrition Reviews
  71. OJO
    Michael Nolting, Ulf Wittke · 2019 · International Conference on Pervasive Computing Technologies for Healthcare
  72. An Exploratory Screening Study for Type 2 Diabetes in Hospitalized Adult Medicine Patients
    Laila Rkieh, Anjana Sengar, Amish Parikh, Allan Mills · 2021 · Canadian Journal of Diabetes
  73. Effectiveness and Cost-Effectiveness of Non-Pharmacological Interventions among Chinese Adults with Prediabetes: A Protocol for Network Meta-Analysis and CHIME-Modeled Cost-Effectiveness Analysis
    Yue Yin, Yusi Tu, Mingye Zhao, Wenxi Tang · 2022 · International Journal of Environmental Research and Public Health
  74. Association between the Diabetes Drug Cost and Cardiovascular Events and Death in Korea: A National Health Insurance Service Database Analysis
    Seung Min Chung, Kyounghoon Lee, Eugene Han, Hyun-Ae Seo, Eon Ju Jeon, Hye Soon Kim, Ji Sung Yoon · 2022 · Endocrinology and Metabolism
  75. Detecting diabetes complications in children
    Rita Ágnes Bertalan, J W Gregory · 2011 · Practical Diabetes
  76. Why We Should Screen for Type 2 Diabetes in High-Risk Patients
    Marian Sue Kirkman · 2013 · American Journal of Preventive Medicine
  77. Policy Statement From the American Heart Association Value of Primordial and Primary Prevention for Cardiovascular Disease : A
    Laura Lucia Hayman, Donald M. Lloyd‐Jones, Dilip K. Pandey, Steven Jay Weintraub, Stephen R. Daniels, Lora E. Burke, Barry A. Franklin · 2011
  78. Approaches to Integrated Diabetes Care: A South African Approach
    Larry A. Distiller, Michael Anthony Brown Sr. · 2016 · Springer eBooks
  79. brechas entre la diabetes, el paciente y el equipo de atención. Estrategia para disminuirlas
    Arturo Orduz, Hernán Urquijo Quintero, Yady Cristina González Álvarez · 2017 · Revista Colombiana de Endocrinología Diabetes & Metabolismo
  80. Behaviour Change Update: Stage 3. BCT analysis of behaviour change interventions reported in studies of cost effectiveness
    Lion Shahab, F Lorrencatto, Emma Beard · 2013 · UCL Discovery (University College London)
  81. The utilisation of public and private health care among Australian women with diabetes: Findings from the 45 and Up Study
    Jon Adams, Erica McIntyre, Amie Steel, Brenda M. Y. Leung, Matthew Leach, David William Sibbritt · 2021 · PLoS ONE
  82. Cost-effectiveness of diabetes screening and diagnosis services for people with TB in the Philippines
    Takuya Yamanaka, Mary Christine Castro, Sharon Elizabeth Cox, Yoko V. Laurence, Anna Vassall · 2025 · Diabetes Research and Clinical Practice
  83. Multidisciplinary lifestyle treatment for type 2 diabetes in 12 European countries: protocol for a quasi-experimental study
    Isabel Diez Valcarce, Marta María Pisano González, Cristina Fernández García, Jaana Lindström, Jelka Zaletel, Claudia Giacomozzi, Foetini Tolika, Inés Rey Hidalgo, Alberto Lana · 2025 · BMC Public Health
  84. NutricARe - An Augmented Reality Serious Game to Educate Type 2 Diabetics During Hospital Stays
    Jannik Elias Waldraff, Christian Eichhorn, David Alexander Plecher · 2025 · IEEE Conference on Games (CoG)
  85. Impact of philanthropic investment on integrating social determinants of health into diabetes care at US federally qualified health centers
    Sonak Dinesh Pastakia, Alycia Clark, Katie Lewis, Damon Taugher, Omolola A. Adeoye‐Olatunde, Kourtney A. D. Byrd, Kay Johnson, Andrew M. Gonzales, Nader Tossoun, D Cortez et al. · 2025 · Dialogues in Health
  86. Behavioral and Sociodemographic Predictors of Diabetes Among Non-Hispanic Multiracial Adults in the United States: Using the 2023 Behavioral Risk Factor Surveillance System
    Ermias Abera Turuse, Sherli Koshy-Chenthittayil, Amy E.L. Stone, Edom Gelaw, Courtney Coughenour · 2025 · International Journal of Environmental Research and Public Health
  87. Foot self-care practices among adults with diabetes in the West Bank, Palestine: A cross-sectional study
    Alhareth M. Amro, Salahaldeen Deeb, Mohammad Harbi Alfrookh, Bushra M. Makhamra, Lama amro, Anas K. Assi, Osama J. Makhamreh, Anas Ameen Ishqair, Afnan W.M. Jobran · 2026 · PLOS Global Public Health
  88. Optimising care for uncomplicated type 2 diabetes mellitus in Lagos, Nigeria: cost and benefit estimates using real-world data
    Martilord Ifeanyichi, Gloria P. Gómez-Pérez, Bolanle Banigbe, Ibironke Dada, Adedamola A. Dada, Emmanuella Zamba, Judith M. van Andel, Tobias F. Rinke de Wit, Charlotte Dieteren · 2026 · BMJ Global Health
  89. Endogenous Glucagon-Like Peptide-1 as a Potential Mediator of the Resolution of Diabetic Kidney Disease following Roux en Y Gastric Bypass: Evidence and Perspectives
    Neil Gerard Docherty, Carel Wynand le Roux · 2014 · Advances in Endocrinology
  90. Approach to Lipid Screening as a Risk Marker for Cardiovascular Disease in Pediatric Patients with Diabetes
    Jennifer Rachel Law, Shipra Patel, Anna Spagnoli · 2011 · Frontiers in Endocrinology
  91. Differences in Statin Usage and Target-Goal Achievement between Departments at the Same Hospital
    Zhong Chen, Xin Wang, Zhen Ding, Peiying Fan, Genshan Ma · 2012 · PLoS ONE
  92. A quantitative analysis of diabetic retinopathy screening in a regional treatment centre.
    M James, Heng Th, Diana Minasyan · 2014 · PubMed
  93. THE ECONOMIC COSTS OF NONCOMMUNICABLE DISEASES IN THE
    Pacific Islands · 2013
  94. The Economic Impact of a Pharmacy-Based Hybrid Medication Adherence Model in Patients with Metabolic Syndrome
    Kevin Edward Omerza · 2015 · OhioLink ETD Center (Ohio Library and Information Network)
  95. Cost-effectiveness of coronary clinical intervention: a retrospective analysis
    Rajasekharan Pillai K., Sunaina G. Fernandes · 2019 · Journal of Public Health
  96. Gesundheitsökonomische Evaluation von Präventions- und Managementstrategien bei Diabetes
    Michael Laxy, Katharina Kähm · 2019 · Der Diabetologe
  97. Cost Effectiveness of ACEIs/ARBs versus Amlodipine Monotherapies: A Single-Center Retrospective Chart Review
    Yazed Sulaiman AlRuthia, Fahad Alotaibi, Amr A Jamal, Ibrahim Sales, Monira Alwhaibi, Nawaf Abdullah Alqahtani, Sina M. AlNajrany, Khalid Abdulrahman Almalki, Abdulaziz Al-Saigh, Wael Mansy · 2021 · Healthcare
  98. The Extent of Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes in Clinical Practice
    Rutul A. Gokalani, Dharmendra Panchal, Banshi Saboo, Padmanabh Zinzuwadia, Dishank Patel, Rupam Chaudhury, Vipul Chavda, Sanjeev Phatak, Renuka Prasad, S. S. Dariya et al. · 2021 · Journal of Diabetology
  99. Mobile Health Technologies
    Yaser Mohammed Al‐Worafi · 2022 · CRC Press eBooks
  100. Effect of physical activity counselling on the number of contacts in primary healthcare, specialised healthcare and the related healthcare costs among patients with type 2 diabetes: a register-based evaluation study
    Tuula Martiskainen, Marja‐Leena Lamidi, Miika Linna, Mika Venojärvi, Heikki Olavi Tikkanen, Tiina K. Laatikainen · 2023 · BMJ Public Health